Updated: Clinical and Genetic Significance of Chromosomal Microarray Screening of Asymptomatic Newborns
pmc changed: 17 sentences were added and 42 were removed since we last looked.
How this was derived
Version 2 captured 2026-11-14. Newly added text includes: “1 Introduction Chromosomal microarray analysis (CMA) is a first‐tier diagnostic tool to identify chromosomal anomalies in patients with multiple congenital anomalies, unexplained developmental delay, intellectual disability, or autism spectrum disorder [ 1 ]. 2 Materials and Methods 2.1 Patients We retrospectively analyzed medical records of asymptomatic neonates referred to the Genetics Clinic at”
Generated 2026-11-14, last changed
today. Dedup key update:208.
The engine re-checks this insight on every analysis run; if more sources agree, its corroboration and confidence go up and it reappears as “new”.
Evidence (1 quote)
1 Introduction Chromosomal microarray analysis (CMA) is a first‐tier diagnostic tool to identify chromosomal anomalies in patients with multiple congenital anomalies, unexplained developmental delay, intellectual disability, or autism spectrum disorder [ 1 ]. 2 Materials and Methods 2.1 Patients We retrospectively analyzed medical records of asymptomatic neonates referred to the Genetics Clinic at
Supporting documents (1)
| Story | Source | Published | Seen | Relevance |
|---|---|---|---|---|
| Clinical and Genetic Significance of Chromosomal Microarray Screeni... | pmc | 2026-01-01 | yesterday | 1.00 |